Engineered Spiky Silica Nanoparticles as Effective Immune Adjuvants by Activating Inflammasome and Enhancing Cellular Uptake

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1124265

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Vaccination is a triumph of preventative healthcare in Australia and worldwide. Despite substantial advances in vaccine development, some of the most lethal diseases still lack effective vaccines. This project aims to generate a novel immune adjuvant with excellent safety to promote antigen immunity by rationally designing surface structure of nanomaterials. Successful completing of this project has great potential to bring new, safe and potent vaccines for some infectious disease and cancer.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2020

Funding Scheme: Early Career Fellowships

Funding Amount: $318,768.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Biotechnology not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

adjuvant | biomedical engineering | immunology | nanotechnology | vaccine development

Related Links